Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
COVID vaccination gives huge boost to post-infection immunity
Fri February 26th - Vaccination is acting as a booster dose for people already enjoying some protection against COVID-19 after exposure to the disease, British scientists reported last night. More
Increased opioid agonist treatment could reduce drug deaths
Fri February 26th - Scaling up the use of opioid agonists could help to reduce drug-related deaths substantially, new international research claims. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Lab-grown organoids repair damaged human livers

Friday February 19th 2021

Laboratory-grown organoids have been used for the first time to repair damaged human livers, potentially paving the way for cell therapies to treat liver disease, British researchers have announced.

Writing in the February edition of Science, scientists at the University of Cambridge, UK, say their new approach takes advantage of a recently introduced “perfusion system”, which can be used to maintain donated organs outside the body.

Using this technology, they showed it is possible to transplant lab-grown cholangiocytes into damaged human livers to repair them.

As proof-of-principle, they repaired livers deemed unsuitable for transplantation due to bile duct damage and say their approach could be applied to multiple organs and diseases to accelerate the clinical application of cell-based therapy.

Dr Fotios Sampaziotis from the Wellcome-MRC Cambridge Stem Cell Institute said: “Given the chronic shortage of donor organs, it’s important to look at ways of repairing damaged organs, or even provide alternatives to organ transplantation.

“We’ve been using organoids for several years now to understand biology and disease or their regeneration capacity in small animals, but we have always hoped to be able to use them to repair human damaged tissue. Ours is the first study to show, in principle, that this should be possible.”

Using the techniques of single-cell RNA sequencing and organoid culture, the researchers discovered that although duct cells differ, biliary cells from the gallbladder, which is usually spared by the disease, could be converted to the cells of the intrahepatic ducts, and vice versa, using bile acid.

This means the patient’s own cells from disease-spared areas could be used to repair destroyed ducts.

To test the hypothesis, the researchers grew gallbladder cells as organoids in the lab, which were grafted into mice. It was found they could repair damaged ducts, opening up avenues for regenerative medicine applications in the context of diseases affecting the biliary system.

The team went on to use the technique on human donor livers and injected the gallbladder organoids into the human liver and showed for the first time that the transplanted organoids repaired the organ’s ducts and restored their function.

Joint senior author Professor Ludovic Vallier, from the Wellcome-MRC Cambridge Stem Cell Institute, said: “This is the first time that we’ve been able to show that a human liver can be enhanced or repaired using cells grown in the lab. We have further work to do to test the safety and viability.”

Mr Kourosh Saeb-Parsy, from the Department of Surgery at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, joint senior author, added: “This is an important step towards allowing us to use organs previously deemed unsuitable for transplantation. In future, it could help reduce the pressure on the transplant waiting list.”

Sampaziotis F et al. Cholangiocyte organoids can repair bile ducts after transplantation in human liver. Science 18 February 2021

Tags: Internal Medicine | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)